Afzal Shaik

Prof. Dr. Afzal Shaik

Dr Samuel George Institute of Pharmaceutical Sciences, Mārkāpur, Andhra Pradesh, International
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
BBBulti Bakchi
Bulti Bakchi
AKAmbati Dileep Krishna
Ambati Dileep Krishna
ESEkambarapu Sreecharan
Ekambarapu Sreecharan
VGVeeramallu Bala Jaya Ganesh
Veeramallu Bala Jaya Ganesh
MNMuraboina Niharika
Muraboina Niharika
ASAfzal Shaik
Afzal Shaik

26 February 2020 in Molecules
Verified
Journal Article
Open access
PDF file
ASAfzal Shaik
Afzal Shaik
RBRichie Bhandare
Richie Bhandare
KPKishor Palleapati
Kishor Palleapati
SNSRINATH NISSANKARARAO
SRINATH NISSANKARARAO
VKVenkata Kancharlapalli
Venkata Kancharlapalli
SSShahanaaz Shaik
Shahanaaz Shaik
Our previous work identified isoxazole-based chalcones and their dihydropyrazole derivatives as two important five-membered heterocycles having antitubercular activity. Hence, in the present study, we biologically evaluated 30 compounds, including 15 isoxazole ring-containing chalcones (17–31) and 15 dihydropyrazoles (32–46) derived from these chalcones for their antimicrobial, antioxidant, and anticancer activities. Chalcones exhibited superior antibacterial and antioxidant activities compared to dihydropyrazoles. Among the chalcones, compound 28 showed potent antibacterial (MIC = 1 µg/mL) and antioxidant activities (IC50 = 5 ± 1 µg/mL). Dihydropyrazoles, on the contrary, demonstrated remarkable antifungal and anticancer activities. Compound 46 (IC50 = 2 ± 1 µg/mL) showed excellent antifungal activity whereas two other dihydropyrazoles 45 (IC50 = 2 ± 1 µg/mL) and 39 (IC50 = 4 ± 1 µg/mL) exhibited potential anticancer activity. The compounds were also tested for their toxicity on normal human cell lines (LO2) and were found to be nontoxic. The active compounds that have emerged out of this study are potential lead molecules for the development of novel drugs against infectious diseases, oxidative stress, and cancer.

21 December 2021 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
SVSantosh Kumar Verma
Santosh Kumar Verma
RVRameshwari Verma
Rameshwari Verma
YGYarabahally R. Girish
Yarabahally R. Girish
FXFan Xue
Fan Xue
LYLong Yan
Long Yan
KRKanchugarakoppal Rangappa
Kanchugarakoppal Rangappa
In recent years, g-C3N4 photocatalyst-mediated organic reactions have represented an important mode of chemical transformations and are expected to become a crucial field at the forefront of organic chemistry. Polymeric g-C3N4 as a heterogeneous catalyst has attracted great attention compared to other metal-based catalysts in photocatalytic applications because of its cost-effectiveness, good chemical stability, no heavy metal pollution, and eco-friendliness. In recent years, aerobic oxidation under visible-light has been identified as an attractive and fast-developing field in synthetic chemistry due to the simple operating procedure, easy work up and high efficiency. This review highlights carbon nitride-catalyzed visible-light-promoted strategies for the oxidation of alcohols, synthesis of esters, phenols, and sulfoxides, reduction of nitro compounds, the formation of carbonyl compounds, and several coupling reactions. However, g-C3N4 demands high temperature and O2 pressure in addition to visible-light in the system to deliver the desired organic transformations. An alternative strategy may be to anchor organic dyes on the surface of heterogeneous catalysts for mild reaction conditions. The more challenging reaction is the reduction, since investigations related to the selective photoreduction of organic substrates are limited in comparison with photocatalytic selective oxidation; specifically, g-C3N4 is restricted to nitro compounds predominantly. Attempts can be made to enhance the selectivity in reduction by modifying surfaces, changing external conditions, forming composites, etc.

22 December 2021 in ACS Omega
Verified
Journal Article
Open access
AMAyman Mohamed
Ayman Mohamed
Khaled DarwishKhaled Darwish
Khaled Darwish
ACAmani chrouda
Amani chrouda
ABAmira Abdel Halim Boseila
Amira Abdel Halim Boseila
MTMohamed A. Tantawy
Mohamed A. Tantawy
Ahmed A. Al-KarmalawyAhmed A. Al-Karmalawy
Ahmed A. Al-Karmalawy
Cancer is a leading cause of death worldwide and its incidence is unfortunately anticipated to rise in the next years. On the other hand, vascular endothelial growth factor receptor 2 (VEGFR-2) is highly expressed in tumor-associated endothelial cells, where it affects tumor-promoting angiogenesis. Therefore, VEGFR-2 is considered one of the most promising therapeutic targets for cancer treatment. Furthermore, some FDA-approved benzimidazole anthelmintics have already shown potential anticancer activities. Therefore, repurposing them against VEGFR-2 can provide a rapid and effective alternative that can be implicated safely for cancer treatment. Hence, 13 benzimidazole anthelmintic drugs were subjected to molecular docking against the VEGFR-2 receptor. Among the tested compounds, fenbendazole (FBZ, 1), mebendazole (MBZ, 2), and albendazole (ABZ, 3) were proposed as potential VEGFR-2 antagonists. Furthermore, molecular dynamics simulations were carried out at 200 ns, giving more information on their thermodynamic and dynamic properties. Besides, the anticancer activity of the aforementioned drugs was tested in vitro against three different cancer cell lines, including liver cancer (HUH7), lung cancer (A549), and breast cancer (MCF7) cell lines. The results depicted potential cytotoxic activity especially against both HUH7 and A549 cell lines. Furthermore, to improve the aqueous solubility of MBZ, it was formulated in the form of mixed micelles (MMs) which showed an enhanced drug release with better promising cytotoxicity results compared to the crude MBZ. Finally, an in vitro quantification for VEGFR-2 concentration in treated HUH7 cells has been conducted based on the enzyme-linked immunosorbent assay. The results disclosed that FBZ, MBZ, and ABZ significantly (p < 0.001) reduced the concentration of VEGFR-2, while the lowest inhibition was achieved in MBZ-loaded MMs, which was even much better than the reference drug sorafenib. Collectively, the investigated benzimidazole anthelmintics could be encountered as lead compounds for further structural modifications and thus better anticancer activity, and that was accomplished through studying their structure–activity relationships.

3 January 2023 in BioTech
Verified
Journal Article
Open access
PDF file
JLJada Naga Lakshmi
Jada Naga Lakshmi
ABAnkem Narendra Babu
Ankem Narendra Babu
SKS. S. Mani Kiran
S. S. Mani Kiran
LNLAKSHMI PRASANTHI NORI
LAKSHMI PRASANTHI NORI
NHNageeb A.G.M. Hassan
Nageeb A.G.M. Hassan
ASAfzal Shaik
Afzal Shaik
Background: Polycystic ovarian syndrome (PCOS) is a neuroendocrine metabolic disorder characterized by an irregular menstrual cycle. Treatment for PCOS using synthetic drugs is effective. However, PCOS patients are attracted towards natural remedies due to the effective therapeutic outcomes with natural drugs and the limitations of allopathic medicines. In view of the significance of herbal remedies, herein, we discuss the role of different herbs in PCOS. Methods: By referring to the Scopus, PubMed, Google Scholar, Crossref and Hinari databases, a thorough literature search was conducted and data mining was performed pertaining to the effectiveness of herbal remedies against PCOS. Results: In this review, we discuss the significance of herbal remedies in the treatment of PCOS, and the chemical composition, mechanism of action and therapeutic application of selected herbal drugs against PCOS. Conclusions: The present review will be an excellent resource for researchers working on understanding the role of herbal medicine in PCOS.

9 November 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Surendra babu LaguSurendra babu Lagu
Surendra babu Lagu
RYRajendra Prasad Yejella
Rajendra Prasad Yejella
RBRichie Bhandare
Richie Bhandare
ASAfzal Shaik
Afzal Shaik
Despite the availability of many drugs to treat infectious diseases, the problems like narrow antimicrobial spectrum, drug resistance, hypersensitivities and systemic toxicities are hampering their clinical utility. Based on the above facts, in the present study, we designed, synthesized and evaluated the antibacterial and antifungal activity of novel fluorinated compounds comprising of chalcones bearing trifluoromethyl (A1–A10) and trifluoromethoxy (B1–B10) substituents. The compounds were characterized by spectroscopic techniques and evaluated for their antimicrobial activity against four pathogenic Gram-positive (Staphylococcus aureus and Bacillus subtilis) and Gram-negative (Escherichia coli and Bacillus subtilis) bacterial and fungal (Candida albicans and Aspergillus niger) strains. In this study, the compounds with trifluoromethoxy group were more effective than those with trifluoromethyl group. Among the 20 fluorinated chalcones, compound A3/B3 bearing an indole ring attached to the olefinic carbon have been proved to possess the most antimicrobial activity compared to the standard drugs without showing cytotoxicity on human normal liver cell line (L02). Further, the minimum inhibitory concentration (MIC) for A3/B3 was determined by serial tube dilution method and showed potential activity. These results would provide promising access to future study about the development of novel agents against bacterial and fungal infections.